🇮🇳印度·创业公司·2026年5月27日·来源： The Economic Times
Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
内容仅提供英文版本
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affor...
分享这篇文章
原文报道： The Economic Times我们不转载全文， 阅读原文 →
